Data showed that fracture risk rises briefly after menopausal hormone therapy discontinuation, then falls below never-users.
Hannah Clarke
Advertisement
Articles by Hannah Clarke
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds
2
FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI
3
Individualized TRT demonstrates broad symptom improvements beyond sexual function
4
SMFM in midst of first annual High-Risk Pregnancy Awareness Week
5